Thompson Kimberly Kraig's Form 4 filing
Kraig Biocraft Laboratories, Inc. (KBLB) · filed Apr 28, 2022
- Accession no.
- 0001493152-22-011442
- Filed
- Apr 28, 2022
- Trade date
- Apr 26-27, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thompson Kimberly KraigCIK 0001837586 | Director, Officer (CEO & CFO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares of the Issuer's Class A Common Stock were sold pursuant to the terms and formula set forth in Mr. Thompson's 10b5-1 trading plan dated February 26, 2019; such sales occurred on April 26, 2022 at $0.072.
Referenced by the price of 1 transaction in Table I.
- F2
These shares of the Issuer's Class A Common Stock were sold pursuant to the terms and formula set forth in Mr. Thompson's 10b5-1 trading plan dated February 26, 2019; such sales occurred on April 27, 2022 at $0.071.
Referenced by the price of 1 transaction in Table I.